Loading...

Flora Growth Corp.

FLGCNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$7.79
$-3.69(-32.14%)
U.S. Market opens in 7h 9m

Flora Growth Corp. Fundamental Analysis

Flora Growth Corp. (FLGC) shows weak financial fundamentals with a PE ratio of -0.76, profit margin of -30.52%, and ROE of -12.27%. The company generates $0.0B in annual revenue with weak year-over-year growth of -40.05%.

Key Strengths

Cash Position166.95%
PEG Ratio0.01

Areas of Concern

ROE-12.27%
Operating Margin-30.74%
We analyze FLGC's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -89.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-89.9/100

We analyze FLGC's fundamental strength across five key dimensions:

Efficiency Score

Weak

FLGC struggles to generate sufficient returns from assets.

ROA > 10%
-3.40%

Valuation Score

Excellent

FLGC trades at attractive valuation levels.

PE < 25
-0.76
PEG Ratio < 2
0.01

Growth Score

Weak

FLGC faces weak or negative growth trends.

Revenue Growth > 5%
-40.05%
EPS Growth > 10%
-32.45%

Financial Health Score

Excellent

FLGC maintains a strong and stable balance sheet.

Debt/Equity < 1
0.76
Current Ratio > 1
1.01

Profitability Score

Weak

FLGC struggles to sustain strong margins.

ROE > 15%
-1227.01%
Net Margin ≥ 15%
-30.52%
Positive Free Cash Flow
No

Key Financial Metrics

Is FLGC Expensive or Cheap?

P/E Ratio

FLGC trades at -0.76 times earnings. This suggests potential undervaluation.

-0.76

PEG Ratio

When adjusting for growth, FLGC's PEG of 0.01 indicates potential undervaluation.

0.01

Price to Book

The market values Flora Growth Corp. at 0.05 times its book value. This may indicate undervaluation.

0.05

EV/EBITDA

Enterprise value stands at 12.69 times EBITDA. This signals the market has high growth expectations.

12.69

How Well Does FLGC Make Money?

Net Profit Margin

For every $100 in sales, Flora Growth Corp. keeps $-30.52 as profit after all expenses.

-30.52%

Operating Margin

Core operations generate -30.74 in profit for every $100 in revenue, before interest and taxes.

-30.74%

ROE

Management delivers $-12.27 in profit for every $100 of shareholder equity.

-12.27%

ROA

Flora Growth Corp. generates $-3.40 in profit for every $100 in assets, demonstrating efficient asset deployment.

-3.40%

Following the Money - Real Cash Generation

Operating Cash Flow

Flora Growth Corp. generates limited operating cash flow of $-10.92M, signaling weaker underlying cash strength.

$-10.92M

Free Cash Flow

Flora Growth Corp. generates weak or negative free cash flow of $-11.60M, restricting financial flexibility.

$-11.60M

FCF Per Share

Each share generates $-21.39 in free cash annually.

$-21.39

FCF Yield

FLGC converts -2.18% of its market value into free cash.

-2.18%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.76

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.008

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.05

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.29

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.76

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.01

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.12

vs 25 benchmark

ROA

Return on assets percentage

-0.03

vs 25 benchmark

ROCE

Return on capital employed

-0.04

vs 25 benchmark

How FLGC Stacks Against Its Sector Peers

MetricFLGC ValueSector AveragePerformance
P/E Ratio-0.7628.81 Better (Cheaper)
ROE-12.27%643.00% Weak
Net Margin-30.52%-44312.00% (disorted) Weak
Debt/Equity0.760.36 Weak (High Leverage)
Current Ratio1.014.50 Neutral
ROA-3.40%-17799.00% (disorted) Weak

FLGC outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Flora Growth Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

21340.04%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-443.29%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

34.37%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ